We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Malaria Test Evaluated In Different Locales

By LabMedica International staff writers
Posted on 20 Jun 2013
Print article
Image: VIKIA Malaria rapid diagnostic test (Photo courtesy of IMAccess).
Image: VIKIA Malaria rapid diagnostic test (Photo courtesy of IMAccess).
A recently introduced malaria rapid diagnostic test (RDT) has been evaluated in an area endemic for the disease in Africa and in a nonendemic setting in Europe.

The RDTs are a useful tool in endemic malaria countries, where light microscopy is not feasible and in nonendemic countries where they can be used as complementary tests to provide timely results in case of microscopy inexperience.

Scientists at the Hospices Civils de Lyon (France) working with colleagues in Mali, tested blood samples that were collected during a 12-months and six-months period in 2011 from patients suspected to have malaria in Lyon and Bamako, respectively. Samples of 877 patients from both sites were included in the study.

The samples were examined by light microscopy, the VIKIA Malaria Ag Pf/Pan RDT (IMAccess; Lyon, France) and in Bamako additionally with the CareStart RDT (AccessBio, Somerset, NJ, USA). All discordant results between microscopy and the two RDTs were resolved by a real time polymerase chain reaction (PCR) and test characteristics were recalculated according to the PCR-corrected results. Sensitivity, specificity, positive predictive value, and negative predictive value were used to evaluate test performance.

The VIKIA Malaria Ag Pf/Pan RDT is an immunochromatographic test in which monoclonal antibodies target the histidine-rich protein II (HRP-II) protein antigen specific to Plasmodium falciparum and the Pan Aldolase antigen, common to all the Plasmodium species. This RDT had sensitivity for Plasmodium falciparum of 98% in Lyon and 96% in Bamako, and its performance was similar to PCR-corrected microscopy. No significant difference in the detection of falciparum and non-falciparum malaria between the two RDTs was observed. The performance of the VIKIA RDT was not significantly different for P. falciparum and non-falciparum species compared to PCR-corrected microscopy method.

The authors concluded that the VIKIA Malaria Ag Pf/Pan showed a similar level of performance to comparative RDTs in endemic and in nonendemic settings. Community health workers were as efficient as medical students in managing malaria cases using both RDTs tested. This RDT, which has recently become commercially available, could be used to implement efficient malaria diagnosis in low-income endemic countries or complement PCR/microscopy diagnosis in nonendemic regions. The study was published on June 6, 2013, in the Malaria Journal.

Related Links:

Hospices Civils de Lyon
IMAccess
AccessBio


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.